Table of contents

Ovarian Cancer

• Advanced Ovarian Cancer Displays Functional Intratumor Heterogeneity That Correlates to Ex Vivo Drug Sensitivity (1 July, 2016)

  Rachel L. O’Donnell, Angelika Kaufmann, Laura Woodhouse, Aiste McCormick, Paul A. Cross, Richard J. Edmondson, Nicola J. Curtin
• Validation of Revised FIGO Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type (1 July, 2016)

  Tayfun Toptas, Elif Pestereli, Onur Erol, Selen Bozkurt, Gulgun Erdogan, Tayup Simsek
• Outcome of Appendicectomies at Surgery for Mucinous Ovarian Neoplasms: Report From A UK Center and Review of Literature (1 July, 2016)

  Debjani Mukhopadhyay, Ramzi Rajab, Marielle Nobbenhuis, James Dilley, Owen Heath, Jayson Wang, Thomas E.J. Ind, Desmond P.J. Barton
• An Integrative Genomic Analysis of Formalin Fixed Paraffin-Embedded Archived Serous Ovarian Carcinoma Comparing Long-term and Short-term Survivors (1 July, 2016)

  Karin Stålberg, Joakim Crona, Masoud Razmara, Diana Taslica, Britt Skogseid, Peter Stålberg
• Investigating the Impact of Body Mass Index on Intraperitoneal Chemotherapy Outcomes in Ovarian and Fallopian Tube Cancer (1 July, 2016)

  Michelle Davis, Emeline Aviki, J. Alejandro Rauh-Hain, Michael Worley, Ross Berkowitz, John Schorge, Michael Muto, Rachel Clark Sisodia, Neil Horowitz, Marcela del Carmen
• Transvaginal Sonography-Guided Core Biopsy of Adnexal Masses as a Useful Diagnostic Alternative Replacing Cytologic Examination or Laparoscopy in Advanced Ovarian Cancer Patients (1 July, 2016)

  Tae-Wook Kong, Suk-Joon Chang, Jiheum Paek, Hana Cho, Yonghee Lee, Eun Ju Lee, Hee-Sug Ryu
• Activity of Bevacizumab in Patients With Low-Grade Serous Ovarian Carcinoma (1 July, 2016)

  Peter G. Rose, Haider Mahdi, Amelia Jernigan, Bin Yang
• The Evaluation of Risk Factors Associated With Relapse and Recurrence of Borderline Ovarian Tumors With Long-Term Follow-up (1 July, 2016)

  Piotr Sobiczewski, Jolanta Kupryjanczyk, Wojciech Michalski, Beata Śpiewankiewicz
• Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting (1 July, 2016)

  Gwendolin Manegold-Brauer, Johanna Buechel, Alexandra Knipprath-Mészaros, Andreas Schoetzau, Neville F. Hacker, Sevgi Tercanli, Olav Lapaire, Viola Heinzelmann-Schwarz
• Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer (1 July, 2016)

  Archana R. Simmons, Charlotte H. Clarke, Donna B. Badgwell, Zhen Lu, Lori J. Sokoll, Karen H. Lu, Zhen Zhang, Robert C. Bast, Steven J. Skates
• Wnt Signaling and Survival of Women With High-Grade Serous Ovarian Cancer: A Brief Report (1 July, 2016)

  Brandon-Luke L. Seagle, Monica Dandapani, Judy Y. Yeh, Shohreh Shahabi